Bac-EPIC: A web interface for developing novel efflux pump inhibitor compounds targeting Escherichia coli
Multidrug resistance (MDR) poses a severe threat to human health. The existence of efflux pumps primarily contributes to resistance in Gram-negative bacterial infections. Efflux pump inhibitors (EPIs) can potentially improve the efficacy of antibiotics and reduce bacterial pathogenicity by inhibitin...
Main Authors: | Shweta Singh Chauhan, Priyam Pandey, Sabrina Manickam, Ramakrishnan Parthasarathi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098623000143 |
Similar Items
-
Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition
by: Ariel M. Langevin, et al.
Published: (2020-12-01) -
Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli
by: Rawaf Alenazy
Published: (2024-04-01) -
Molecular determinant deciphering of MIC-guided RND efflux substrates in E. coli
by: Johan Revol-Tissot, et al.
Published: (2024-03-01) -
The Multidrug Efflux Regulator AcrR of Escherichia coli Responds to Exogenous and Endogenous Ligands To Regulate Efflux and Detoxification
by: Dana E. Harmon, et al.
Published: (2022-12-01) -
Sodium Malonate Inhibits the AcrAB-TolC Multidrug Efflux Pump of <i>Escherichia coli</i> and Increases Antibiotic Efficacy
by: Allea Cauilan, et al.
Published: (2022-11-01)